Trienbio, led by CEO Yong-Soo Kim, announced on July 1-3, its participation in In-Cosmetics Korea 2026, where it showcased next-generation bio-based cosmetic ingredients and proprietary technologies. This exhibition serves as a collaborative platform for local and international cosmetic ingredient companies, brands, and research institutions to share the latest technologies and market trends.
At the event, Trienbio focused on plant-derived bio materials and next-generation delivery systems, engaging in extensive consultations with global buyers. The significant attendance from buyers across Asia, Europe, and North America indicates a growing international interest in Trienbio's innovations.
Notably, Trienbio's plant-derived PDRN material garnered the most attention. This ingredient has gained recognition as a core component for skin regeneration and anti-aging applications, capturing the interest of global companies seeking unique ingredients. Some overseas firms expressed intentions to implement Trienbio's PDRN technology into their own product development, highlighting the brand's technological competitiveness beyond mere ingredient supply.
Exosome materials also attracted steady interest from global buyers. As an emerging bio delivery system, the market potential for exosomes is rapidly growing, with Trienbio's plant-derived exosome technology receiving inquiries for functional cosmetics as well as applications in the premium skincare market.
Another highlight of the exhibition was the debut of Trienbio's Hybrid Oleosome, which captured the attention of attendees who frequently questioned its capabilities. As a relatively unknown material in the market, its distinction from traditional liposomes and exosomes allowed Trienbio to effectively communicate its technical prowess and the potential of this new delivery system.
Trienbio's experience at the exhibition reaffirmed the global market's heightened interest in bio materials that are not only scientifically substantiated but also offer unique delivery technologies. The demand for the raw ingredients themselves, alongside unique patents and differentiated platforms, signals an expanding market in the beauty industry.
A representative from Trienbio stated, "In-Cosmetics Korea was a significant opportunity to engage directly with global clients to ascertain the technologies and products that the market demands. We will continue to develop next-generation bio materials such as plant-derived PDRN, exosomes, and oleosomes, aiming to evolve as a technology-centric company collaborating with global partners."